Lexicon Pharmaceuticals
LXRX
#6298
Rank
S$1.33 B
Marketcap
S$3.01
Share price
0.00%
Change (1 day)
121.88%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -S$33.63 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are S$69.64 Million. In 2025 the company made an earning of -S$64.48 Million, an increase over its 2024 earnings that were of -S$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$33.63 Million-47.85%
2025 -S$64.48 Million-74.88%
2024 -S$0.26 Billion13.15%
2023 -S$0.23 Billion73.74%
2022 -S$0.14 Billion16.16%
2021 -S$0.12 Billion49.82%
2020 -S$75.02 Million-147.19%
2019 S$0.15 B-203.42%
2018 -S$0.16 Billion-15.31%
2017 -S$0.19 Billion0.2%
2016 -S$0.19 Billion2920.7%
2015 -S$6 Million-95.33%
2014 -S$0.13 Billion-3.61%
2013 -S$0.14 Billion-5.52%
2012 -S$0.15 Billion-4.17%
2011 -S$0.15 Billion15.5%
2010 -S$0.13 Billion8.36%
2009 -S$0.12 Billion-4.81%
2008 -S$0.13 Billion28.79%
2007 -S$96 Million35.71%
2006 -S$70.74 Million52.91%
2005 -S$46.26 Million-23.89%
2004 -S$60.78 Million-24.19%
2003 -S$80.17 Million-0.48%
2002 -S$80.55 Million44.12%
2001 -S$55.89 Million23.01%
2000 -S$45.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
S$9.50 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.48 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.60 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.69 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.24 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.10 B-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.77 Million-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$19.11 Million-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA